Best Agrolife Ltd. · NSE:BESTAGRO
Best Agrolife — Q1 FY26 Earnings Presentation
15 slides from Best Agrolife's earnings presentation, Aug 8, 2025
Slide 1: Intimation under Regulation 30 - Corporate Presentation
W? Best Afi: otiferim ited CIN : L74l 1ODLI992PLCIt6773 Stt August,2025 National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, BIock-G, 2Sth Floor, P.f. Towers, Bandra - Kurla Complex Dalal Street, Mumbai-400001 Bandra (E), Mumbai-400051 SCRIP CODE: 539660 SCRIP ID: BESTAGRO Sub:
Slide 2: Q1 FY25-26
"Best AFoufe Limited .* .
Slide 3: Disclaimer
Disclaimer The Presentation is to provide the general background information about the company’s activities as at the date of the presentation. The information contained herein is for general information purposes only and based on estimates and should not be considered as a recommendation that any i
Slide 4: Table of Contents
Table of Contents Company Snapshot Management Comment v Key Highlights FY25 Financial Highlights Way Ahead
Slide 5: Company Snapshot
Company Snapshot 13 th 40 9 10,000+ Largest Indian Warehouses Patented Dealers Agrochemical 21 States Products Company* 4 530+ 800+ 14% Manufacturing units Formulations Employees 3 Year Revenue 7000 MTPA Technical Registrations CAGR 35500 KL Formulation *Agropages Top 20 Indian Agrochemical Companie
Slide 6: Management Comment
Management Comment “This monsoon we observed a mixed season with most parts of India witnessing normal to above normal rainfall with the exception of Telangana and Maharashtra. In certain regions this variability impacted sowing activity. Despite these regular climatic variations, this is a fair yea
Slide 7: Patented Products
Patented Products RONFENTM TRICOLORTM ORISULAMTM DEFENDERTM NEMAGENTM Insecticide (SC) Fungicide (SC) Herbicide (GR) Insecticide + Insecticide (SC) Fungicide (WG) Pyriproxyfen - 8% Trifloxystrobin - 10% Bispyribac Sodium - 0.25% Pymetrozine - 30% Chlorantraniliprole - 4.5% Dinotefuran - 5% Difenocon
Slide 8: Operational Highlights
Operational Highlights • Gross margin improved to 29% from 25% YoY, driven by a superior product mix and cost discipline. • EBITDA margin rose to 12%, up 150 bps YoY. • PAT margin increased to 5%, up from 4% in Q1 FY25. • Sales returns significantly reduced, improving profitability and g inventory h
Slide 9: Business Achievements in FY26
Business Achievements in FY26 01 9(3) FIM Registrations • Cubax Power ExtraTM: • TrishankuTM: • Combination: Spiromesifen 15% + Hexythiazox 2.2% + Abamectin 1.15% SC • Combination: Tolfenpyrad 30% + Pyriproxyfen 10% + Acetamiprid 4% EC • Crops: Chilli • Crops: Chilli and Cotton • Pests: Black Thrips
Slide 10: Financial Highlights
Financial Highlights Revenue From Operations EBITDA* (₹ Crore) (₹ Crore) 519 381 55 46 Q1 FY25 Q1 FY26 Q1 FY25 Q1 FY26 PAT EPS (₹ Crore) (₹ Crore) 21 20 9.00 8.42 Q1 FY25 Q1 FY26 Q1 FY25 Q1 FY26 *EBITDA is calculated excluding other income
Slide 11: Building a Branded Business
Building a Branded Business Branded v/s Institutional Sales 37% 35% 63% 65% Best ManTM FetagenTM Shot DownTM Q1 FY25 Q1 FY26 Branded Institutional Sales Contribution of Patented products in Branded Sales NemagenTM DefenderTM OrrisulamTM 55% 71% 45% 29% Q1 FY25 Q1 FY26 Patented Non-Patented Warden Ex
Slide 12: Consolidated P&L for Q1 FY26
Consolidated P&L for Q1 FY26 Value (INR Cr) Q1 FY26 Q1 FY25 YoY Q4 FY25 QoQ Revenue from Operations 381 519 (27%) 274 39% Gross Margin 111 127 (13%) 63 76% EBITDA* 46 55 (16%) 4 952% EBITDA Margin (%) 12% 11% 150 bps 2% 1043 bps Profit After Tax 20 21 (6%) (22) 191% PAT Margin (%) 5% 4% 110 bps (8)
Slide 13: Consolidated P&L for Q1 FY26
Consolidated P&L for Q1 FY26 Value (INR Cr) Q1 FY26 Q1 FY25 Q4 FY25 Revenue from Operations 381 519 274 Other Income 4 3 1 Total Revenue 385 522 275 Cost of Goods Sold 271 392 212 Employee Benefits Expense 25 26 23 Other Operating Expenses 40 47 35 Total Expenses 336 465 270 EBITDA* 46 55 4 EBITDA M
Slide 14: Experienced Management Team
Experienced Management Team Mr. Vimal Alawadhi Mr. P. N. Karlekar Mr. N Surendra Sai Mr. Vikas Jain Managing Director Director Director Chief Financial Officer A true visionary and a passionate A chemical Engineer from UDCT- one of A passionate technologist and A seasoned finance professional with o
Slide 15: Thank You
Thank You Contact Us: ir@bestagrolife.com (Investor Relations) DISCLAIMER This presentation includes certain forward looking statements and information including statements concerning the outlook for business. The statements are based on certain expectations, assumptions, anticipated developments an